14 employees
TYRX delivers site-specific therapy by commercializing medical-pharmaceutical combination devices for multiple surgical markets.
1998
$20M
from 3 investors over 3 rounds
TYRX, Inc raised $20M on December 8, 2010
Investors: HLM Venture Partners, Clarus Ventures, LLC and Pappas Ventures